Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02927652 · ClinicalTrials.gov registry record
Psychiatric Comorbidity
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 463
- Enrollment target
NCT02927652: Completed study, sponsored by Duke University.
NCT02927652 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 463 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02927652 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 463 participants
- Enrollment target
Study Summary
The goals of this project are aimed at the following: 1. Identifying psychiatric comorbidity in patients presenting to the HNSCS clinic 1F and Duke Otolaryngology of Raleigh clinic using the validated assessment tool Brief Symptom Inventory (BSI-18) and the patient control scale. The BSI-18 is an 18 question and patient control an 8 item tool that takes about four minutes to complete. 2. Gathering data regarding patient satisfaction in new patients to the HNSCS clinics via the CG-CAHPS visit survey. 3. Examining relationships between psychiatric comorbidity and patient satisfaction. 4. Examining relationships between psychiatric comorbidity and healthcare system use.
Primary Outcome
Measured by the Brief Symptom Inventory (BSI-18) questionnaire using a 5-point Likert scale ranging from 0 (not at all) to 4 (extremely). Maximum global severity index of 72. Higher scores indicate psychosocial distress.
Interventions
- OTHER Questionnaires
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 463 participants |
| Start Date | 2017-01-23 |
| Est. Completion | 2018-03-28 |
What the finished NCT02927652 record still lists
NCT02927652 is an observational study that tracks outcomes without assigning an intervention. The registered 463 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Questionnaires is the first listed.
NCT02927652 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02927652 about?
NCT02927652 is a clinical study titled "Psychiatric Comorbidity". The goals of this project are aimed at the following: 1. Identifying psychiatric comorbidity in patients presenting to the HNSCS clinic 1F and Duke Otolaryngology of Raleigh clinic using the validated assessment tool Brief Symptom Inventory (BSI-18) and the patient control scale. The BSI-18 is an 1...
What is the current status of trial NCT02927652?
This trial is currently completed. The enrollment target is 463 participants. The study started on 2017-01-23. Estimated completion is 2018-03-28.
What interventions are being tested in trial NCT02927652?
The interventions under investigation include: Questionnaires (OTHER).
Who is sponsoring clinical trial NCT02927652?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04787744 · 464 participants · Phase 2
Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer
- NCT04855656 · 464 participants · Phase 1
Study of Lunresertib Alone or in Combination With RP-3500 or Debio 0123 in Patients With Advanced Solid Tumors
- NCT06283927 · 464 participants
The RECSUR-study: Resection Versus Best Oncological Treatment for Recurrent Glioblastoma (ENCRAM 2302)
- NCT06444295 · 464 participants · NA
Testing the Impact of Thrive App Versions on Alcohol Use and Posttraumatic Stress After Recent Sexual Assault
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI